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Abstract
Context: Lifestyle modifications consist of three components including diet, exercise, and cognitive-behavioral therapy which can
reduce side effects of breast cancer. Cognitive-behavioral therapy is a complementary strategy that promotes new skills for any
treatment. Published trials have investigated the co-efficacies of the two or three components of lifestyle modifications, especially
dietary and cognitive-behavioral interventions in breast cancer survivors.
Evidence Acquisition: This protocol is about a meta-analysis which will systematically report the simultaneous effects of dietary
intervention or physical activity with cognitive-behavioral therapy, or three of them on quality of life, the recurrence levels and
anthropometric measurements among patients with breast cancer and survivors. It was prepared in accordance with the PRISMA-
P checklist and will be performed in accordance with the Cochrane Handbook for Systematic reviews of intervention. Cochrane
Central Register of Controlled trials, PubMed, EMBASE and ISI web of science will be searched for peer-reviewed literature using
defined MeSH terms. Included randomized controlled trials on the combination effects of cognitive-behavioral therapy with either
dietary or physical interventions will be assessed. Continuous data will be meta-analyzed using the STATA and will be gathered using
random-effects models. The effect size will be reported as standardized mean difference with 95%CIs. Heterogeneity assessment,
publication bias, and sensitivity analysis will be performed. The heterogeneity between some trials may be a limitation of this study.
Conclusions: This meta-analysis will provide beneficial guidance for healthcare providers and family members to improve the
current understanding of the role of lifestyle modification on alleviating the important problems of patients with breast cancer.
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1. Context
1.1. Rationale
Breast cancer is the most frequent cancer among
women. The estimated five-year relative survival rate for
50 to 69-year-old women diagnosed with breast cancer be-
tween 2001 and 2013 is over 80% (1). Overall, well-being
of patients after their cancer diagnosis and post-treatment
period is a concern and can affect the breast cancer recur-
rence. Hence, related interventions by maintaining or en-
hancing lifestyle modifications can increase their overall-
wellbeing (2). Furthermore, lifestyle modifications are
highly recommended to patients with breast cancer dur-
ing or after their treatments as an adjunct to standard
breast cancer therapies in order to increase their quality
of life (3, 4). Quality of life is an important factor for ev-
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ery human being, especially for patients, which is affected
by the condition of disease and the length of patient’s life
(5). The exact concept of quality of life is hard to describe
and it mostly relies on the particular comprehension of
disease and health; however, according to the phrase given
by the World Health Organization (WHO), quality of life
includes not only mental, physical, and social health but
cognitive-behavioral working ability and life-long pleasure
which can be measured via different validated scales (5).
On the other hand, based on the Nature definition, lifestyle
modifications not only altering diet and physical activity
but also having new behavioral changes for a long time (6).
With regard to the dietary feature of lifestyle modifi-
cations, related principal aspects include energy intake,
dietary fiber, dietary fat and carbohydrate intakes, micro-
nutrients, and alcohol consumption (7). Considerable at-
tention has subsequently been directed towards energy re-
striction programs that cause reductions in body weight.
There are numerous evidence that shows losing weight is
associated with decreased risk of breast cancer recurrence
(8, 9) and improved quality of life and psychological well-
being (10). As a consequence, the present study will mainly
focus on dietary modifications related to weight loss that
generally include reduced fat and simple carbohydrate in-
takes.
Similar to energy restriction, physical activity also
causes higher quality of life. A previous systematic review
reported that patients with higher physical activity levels
were observed to experience a lower relative risk of can-
cer recurrence and had less intense adverse events com-
pared with those who had less exercise (11). Further, a re-
cent meta-analysis reported that exercise resulted in bene-
ficial effects on quality of life and physical functions of pa-
tients with breast cancer who had different demographic
or clinical characteristics during and following their treat-
ments (12).
Meanwhile, the third substantial component of
lifestyle modifications is cognitive-behavioral therapy
which can be incorporated into breast cancer survivorship
programs (13). In fact, recent comprehensive lifestyle
modification programs consider cognitive-behavioral
strategies as the combination factors between dietary
and physical activity recommendations in order to im-
prove patients’ adherence to a long-term treatment
(14). Promising data have indicated that performing
multidisciplinary lifestyle modifications would provide
patients with comprehensive long-term management of
their disease treatment (15, 16). Beneficial effects were
found via cognitive-behavioral therapy; Lichtenthal et
al. showed that cognitive-behavioral intervention led
to improvements in health worries and interpretation
biases in patients with breast cancer compared with the
control arm (17). Further, cognitive-behavioral therapy
has been shown to have additional benefits to patients’
mood and quality of life (18). However, in spite of such
beneficial effects, insignificant or contrary findings were
also reported (19).
As mentioned above, there are published clinical trial
articles that assessed cognitive-behavioral therapy with ei-
ther dietary intervention or physical activity as well as
the simultaneous effects of three of them among patients
with breast cancer and survivors (20-25). Meffered et al.
(20) postulated that the combined intervention of the
three lifestyle modifications aspects could decrease the re-
currence rate and prevent the obesity risk in overweight
breast cancer survivors. Sanft et al. (22) also found that the
combination of cognitive-behavioral, physical, and dietary
interventions led to a prevention of the disease recurrence
compared with the control group.
With regard to the previous systematic review articles,
there are published studies that separately reported the ef-
ficacies of dietary (26-29), physical (12, 30), and cognitive-
behavioral intervention (31) on quality of life and disease
recurrence of patients with breast cancer and survivors.
Besides, compared to the present study protocol, there is
only one systematic review protocol article that has been
published in 2014 and included only dietary modification
and physical activity features of quality of life and their
relation with breast cancer recurrence, without consid-
ering articles that included cognitive-behavioral therapy
along with the other two aspects; further, the results of
this systematic review protocol has not yet been fully pub-
lished (32). Consequently, there are no meta-analysis or
systematic review articles that specifically report the ef-
fects of either dietary or physical activity interventions
with cognitive-behavioral therapy or even three of them
on quality of life and/or cancer recurrence among patients
with breast cancer and survivors. Hence, performing the
present meta-analysis in order to identify lifestyle related
factors that can improve survival rate and quality of life of
patients during or after the treatment process, would be
of great value. The specific strengths of the present study
would be as followed:
In comparison with similar publications, one of the
aims of this article is to provide a more specific and pre-
cise assessment on the role of lifestyle modification in pa-
tients with breast cancer and the efficacy of its three impor-
tant aspects including dietary, exercise, and psychological
interventions on quality of life of patients with breast can-
cer and survivors.
As cognitive-behavioral therapy is a complementary
therapy that has shown to have long-lasting effects on non-
communicable diseases such as breast cancer, another aim
of this study is to consider those trials that included the
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cognitive-behavioral therapy in the treatment process of
breast cancer along with dietary or physical interventions.
This meta-analysis will provide beneficial guidance for
healthcare providers and family members to augment the
current perception of the function of all the lifestyle modi-
fiable components on alleviating the important problems
of lifestyle of patients with breast cancer.
The beneficial results will prolong the life of breast can-
cer survivors.
The primary objectives of the present study are as-
sessing the simultaneous effects of dietary intervention
or physical activity with cognitive-behavioral therapy, or
three of them, as the main aspects of lifestyle modifica-
tion on quality of life and the recurrence levels among
patients with breast cancer/survivors. The secondary ob-
jectives include the assessment of the above-mentioned
lifestyle modification factors on anthropometric factors,




This systematic review and meta-analysis protocol was
prepared in accordance with the PRISMA-P checklist (Ap-
pendix 1 in Supplementary File) (33). With regard to the in-
structions, this protocol of a systematic review was regis-
tered according to the International Prospective Register
of Systematic Reviews (PROSPERO) on 24 July 2018 and the
last update was on 25 November 2019 (registration num-
ber: CRD42018100628). It will be conducted according to
a format brought in the Cochrane handbook for system-
atic reviews of intervention (34) and the related data will be
reported following the recommendations of PRISMA state-
ment (35). Quantitative extracted data from included ran-
domized clinical trials (RCTs) will be meta-analyzed.
2.2. Eligibility Criteria
2.2.1. Types of Studies
This review study will only include either full-scale
or pilot randomized controlled trials that assessed the
dietary or physical activity interventions with cognitive-
behavioral therapy or the combination of three of them,
compared to a control or usual care. Types of blinding of in-
cluded articles will not be considered as the inclusion cri-
teria and will only be assessed according to the quality as-
sessment tools. The control group for every intervention
part can be either a watchful-waitlist as passive control or
groups that received other standard care management or
placebo as active control. No limitations for sample size or
sampling methods will be considered. Trials with before-
after designs will be primarily excluded. We will exclude
studies if they are animal or in-vitro models. Any records
without full texts will also be excluded as well as the stud-
ies that are irrelevant to the context.
2.2.2. Types of Participants
Eligible participants will include patients aged 18 to 65
with breast cancer stage I to III who are undergoing treat-
ment process as well as breast cancer survivors who have
completed their treatments in the previous 10 years. No
ethnicity limitation will be considered.
2.2.3. Types of Intervention
Intervention types of included RCTs will consist of
lifestyle modification including three main aspects which
are dietary interventions, physical activity, and cognitive-
behavioral interventions. Dietary interventions will con-
sist of dietary counseling and programs including particu-
lar diets for weight management such as a low-calorie diet,
low-carbohydrate, and/or low-fat diets that are performed
individually or through group meetings or those that are
given by telephone calls or mail correspondence, particu-
lar for weight management. We will not consider other di-
etary modifications that include smoking cessation, alco-
hol consumption, or different supplement therapies. Phys-
ical activity intervention will consist of any type of exercise
with different duration. Trials with cognitive-behavioral
interventions will be included which have been given ei-
ther via a face-to-face conversation or by online mode.
2.3. Information Sources
One reviewer (ER) will search electronic databases, in-
cluding Scopus, ISI Web of Science, Pubmed, the Cochrane
Central Register of Controlled Trials, CINAHL, and EMBASE
for peer-reviewed literature. No time limitations will be
considered and the search will be performed after the sub-
mission.
The search strategy will include related keywords of
breast cancer which will be separately combined with the
synonyms of either of the dietary intervention, cognitive-
behavioral therapy, or physical activity (Appendix 2 in Sup-
plementary File).
We will also perform Grey literature by the “GREY MAT-
TERS” checklists which are from the Canadian Agency for
Drugs and Technologies in Health (CADTH).
There will be no language restrictions and the searches
will be re-conducted right before the final analysis. Transla-
tion tools will be used for articles in languages other than
English.
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2.4. Search Strategy
Related keywords that will be used in the search strat-
egy will consist of selected keywords from the Medical
Subject Headings (MeSH) database and the other non-
MeSH terms. The MeSH terms will be made for sequential
searches. Other synonyms of every three of the main com-
ponents will also be searche’d separately. Final search re-
sults will be concatenated with BOOLEAN operators includ-
ing “OR” for the synonyms and “AND” for every combina-
tion between the “breast cancer” component and each of
the three intervention keywords.
2.5. Study Records
2.5.1. Data Management
Two researchers (AS and ER) will conduct the main
management of the study. Data collection will be per-
formed according to the PRISMA flow diagram for report-
ing systematic reviews and meta-analyses studies (36).
Hence, all of the pooled records will be automatically du-
plicated. As finding duplicates via EndNote software (ver-
sion 8.2, Thomson Reuters, Philadelphia, USA) are inad-
equate, further duplication will be performed via hand-
searching.
2.5.2. Selection Process
Five reviewers (AS, ER, MZ, MB, and AM) will perform the
screening of titles and abstracts of studies according to the
mentioned inclusion and exclusion criteria. All reviewers
will meet and compare their screening at least three times
to compare and discuss the related results. If any doubt
still exists, the full text of the related study will be checked
for more precise assessment.
2.5.3. Data Collection Process
The five reviewers (AS, ER, MB, MZ, and AM) will review
the full texts of articles and will perform data extraction in-
dependently for each study via a standardized form which
is from the Cochrane Data Collection for Randomized Con-
trolled trials (37). The data which will be extracted are as
followed:
1) The basic characteristics of the study including the
author names, publication year and the region of the pub-
lished article as well as the methodological quality and
the design of each study including randomized or non-
randomized, pilot, or full trials.
2) Characteristics of trial participants including total
participants, age, breast cancer stage, type of treatment,
breast cancer biological subtype, and ethnicity.
3) Type of interventions including diet or exercise inter-
vention with psychotherapy or three of them along with
details of the interventions and durations versus the con-
trol groups.
4) Outcome measures and their definitions and units;
the drop-out and completion rates, the measurement
tools, and the final analysis with or without adjusted vari-
ables and the per-protocol or intention-to-treat analysis.
Data will be separately entered for studies that have
more than one outcome measure in order to conduct in-
dividual analysis. We will calculate the mean differences of
selected data in SPSS (version 20, IBM, Chicago IL, USA). Data
type in the present meta-analysis will be means and stan-
dard deviations of continuous data among participants
either in the intervention or control groups and if data
present in forms other than means and standard devia-
tions, they will be accordingly converted in order to con-
duct the pooled analysis. Two reviewers will revise the ac-
curacy of the extracted data (AS and ER) and they will re-
solve any discrepancies or disagreement through group
discussion by re-checking the extracted data and full texts
of all articles.
2.6. Outcomes and Prioritization
The following primary and secondary outcome mea-
surements will be evaluated and analyzed based on the re-
ported data from every included trial:
2.6.1. Primary Outcomes Measure
Quality of life and disease recurrence rates.
2.6.2. Secondary Outcomes Measure
Anthropometric factors, including weight, BMI, waist-
hip ratio, and/or body fat.
2.7. Quality Assessment
2.7.1. Risk of Bias Assessment
The risk of bias of all the included studies will be as-
sessed one by one by the reviewers using the Cochrane col-
laboration’s risk of bias assessment tool (38, 39). There
will be Six main domains of bias which will be assessed,
including selection, attrition, detection, performance, re-
porting bias, and other biases, all of which will be evalu-
ated through the Review Manager software and then will
be classified as either “high-risk”, “low-risk” or “by some
concern” (39). The disagreements will be checked through
meetings in the Breast Cancer Research Center.
2.7.2. Quality of Evidence
We used the Grading of Recommendations Assess-
ment, Development, and Evaluation (GRADE) approach to
assess the quality of evidence for each outcome according
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to the following domains: risk of bias, publication bias, im-
precision of results, heterogeneity, and indirectness of ev-
idence (40). Finally, the quality of evidence will be catego-
rized as very low, low, moderate, and high.
2.8. Data Synthesis
The STATA software (version 14.2, College Station, Texas,
USA) will be used as the principal software for conduct-
ing meta-analysis. The random-effects model will be per-
formed to take into account the between-study variations.
For each outcome measure, means and standard devia-
tions of continuous data of every included study, will be
extracted and analyzed and finally, standardized mean dif-
ference (SMD) with their corresponding standard errors
(SEs) will be calculated. The text and quantitative data will
be checked by the two main reviewers (AS and ER). In case
of incomplete or missing data presents, attempts will be
made to communicate with the original authors of pub-
lished articles to receive full texts of more clarifications.
2.8.1. Assessment of Heterogeneity and Publication Bias
The heterogeneity of studies will be assessed using the
I-squared and Cochra’s Q-statistical tests (41). Heterogene-
ity will be considered important if the I-squared statis-
tic will be more than 50%. Then, if the heterogeneity
presents, sub-group analyses will be performed to identify
the source of heterogeneity based on between-study differ-
ences of included studies.
The publication bias will be performed with Begg’s ad-
justed rank correlation and the Egger’s tests (42). In the
present of asymmetry, the “trim and fill” method will be
used for performing more adjustment of publication bias
(43).
2.8.2. Sensitivity Analysis
Sensitivity analysis will be conducted to assess the ro-
bustness of the measures and to understand the extent to
which the conclusions depend whether upon a particular
study or a group of studies. In fact, by using sensitivity
analysis, the effect of included studies which have higher
levels of missing data will also be evaluated in the overall
assessment of treatment effect.
The levels of attrition will be noted for included stud-
ies. As far as possible, the analyses will be performed ac-
cording to an intention-to-treat basis. Thus, participants
will be analyzed regardless of whether they received the al-
located intervention and only the group that they were al-
located will be considered for the analysis.
3. Discussion
This meta-analysis includes a complete aspects of
lifestyle modification and, when will be done, will pro-
vide beneficial guidance for healthcare providers and fam-
ily members to better understand the role of modifiable
lifestyle factors on alleviating their major problems which
will prolong breast cancer survivors’ lives.
The limitations of the present study may be the hetero-
geneity from some trials.
3.1. Ethics, Knowledge Dissemination and Impact of Study
The ethics and feasibility of the present study is regis-
tered at Academic Center for Education, Culture and Re-
search, ACECR, Department of Breast Cancer, Tehran, Iran
(no.: IR.ACECR.IBCRC.REC.1397.102). The authors believe
that this meta-analysis will provide critical evidence-based
guidance for government or priority setters as well as
healthcare stakeholders in determining whether lifestyle
modification is a prior and preferred remedy for breast
cancer-related outcomes among its patients and survivors.
All data in this study will be saved and managed elec-
tronically and password will be encrypted. In addition,
backup of data will be made on USB flash drives.
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